Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 112 participants.
Also called NCT06250257
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 112 participants
- Registry
-
NCT06250257
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Ethiopia
- Registry status
- Recruiting
Technical summary
Registry record NCT06250257. Randomized; no masking; primary purpose treatment. Start 2024-10-21 (actual); primary completion 2026-05-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
- Condition
- Dilated Cardiomyopathy
- Intervention (Drug)
- Bromocriptine mesylate plus standard GDMT
- Lead sponsor
- Jimma University
- Collaborator
- Ludwig-Maximilians - University of Munich
Record details
- Record id
cardio:ct-nct06250257- Content hash
fa29cc350203e52be455ceff22ad0d08a0a207877c8e8f3236a4b0f6a5133029